SCHEMBL332701

SCHEMBL332701

O=C(O)Cc1c(C(=O)O)c2cc(Oc3ccc(Cl)c(Cl)c3)ccc2n1-c1ccc(OC(F)C(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
USP14 P54578 1/20 0.37
PPARG P37231 6/20 0.37
KDM4E B2RXH2 2/20 0.36
KMO O15229 1/20 0.36
HIF1A Q16665 1/20 0.35
FFAR1 O14842 1/20 0.35
GAA P10253 1/20 0.35
AGTR1 P30556 1/20 0.34
TP53 P04637 1/20 0.34
PPARA Q07869 3/20 0.33
THRA P10827 2/20 0.33
THRB P10828 2/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL334287 0.87 FFAR1 (0.43) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL1407175 0.86 PPARG (0.39) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL332700 0.84 MEN1 (0.41) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL332699 0.83 PPARG (0.38) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL504142 0.81 MEN1 (0.44) MEN1KMT2AUSP14PPARGFFAR1
SCHEMBL503872 0.81 USP14 (0.48) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL333664 0.81 KDM4E (0.46) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL333989 0.81 KDM4E (0.46) MEN1KMT2AUSP14PPARGKDM4E
SCHEMBL334235 0.79 BCL2 (0.42) MEN1KMT2AUSP14KDM4EGAA
SCHEMBL333497 0.79 USP14 (0.44) MEN1KMT2AUSP14PPARGKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097623-B2 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics BIOLIPOX AB (SE) 2012-01-17 US disclosed
US-20090076004-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076004-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, AREG MEN1 2066/4885KMT2A 3484/4885USP14 3873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.